We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

Elan and EntreMed Execute License Agreement for NanoCrystal® Technology
News   Jan 11, 2006

Under the terms of the License Agreement, Elan will manufacture EntreMed's Panzem® NCD.

READ MORE

CoGenesys Licenses Intellectual Property Rights for Target Antigen to PDL
News   Jan 11, 2006

PDL will provide CoGenesys with access to its antibody humanization technology platform.

READ MORE

Galapagos Names Director of Medicinal Chemistry at Biofocus
News   Jan 11, 2006

Dr. Angus MacLeod has joined BioFocus as Director of Medicinal Chemistry.

READ MORE

LECO Opens Global Support Center
News   Jan 11, 2006

The new building will house its Service, Customer Training, and Consumables departments, as well as three mobile laboratories.

READ MORE

ATCC Licensing Program Aids Genmab Drug Development
News   Jan 10, 2006

ATCC's non-exclusive licensing program ensures equitable access to reference research materials.

READ MORE

Duke University and Affymetrix Initiate Five-Year Translational Research Collaboration
News   Jan 10, 2006

Duke Researchers will use Affymetrix's GeneChip HT System and arrays to perform large-scale clinical studies.

READ MORE

CombiMatrix' Announces CombiCore™ Access Program with the University of Colorado
News   Jan 10, 2006

University of Colorado to obtain widespread access to CombiMatrix microarray technology.

READ MORE

Chromos Announces Expansion of Pfizer Collaboration
News   Jan 10, 2006

Chromos will use its ACE System to develop a cell line for a Pfizer therapeutic protein product candidate.

READ MORE

Axxam Provides Screening Assays to NIH Chemical Genomics Centre
News   Jan 10, 2006

NIH will use these assays in the screening campaigns within the Molecular Libraries Roadmap Initiative.

READ MORE

Athersys Extends Partnership with Bristol-Myers to Provide Drug Targets
News   Jan 09, 2006

Athersys will provide RAGE technology to Bristol-Myers Squibb with additional validated drug targets for high-throughput screening.

READ MORE